GSK-3 inhibitor LY2090314, Purity ≥98%

Cat. No.: X24-05-ZQ271

GSK-3 inhibitor LY2090314, Purity ≥98%

Synonym: 603288-22-8; LY 2090314; LY-2090314; GSK-3 inhibitor

  • CAS Number: 603288-22-8
  • Compound CID: 10029385
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
LY2090314, soluble in DMSO and warmed ethanol and insoluble in water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3α and GSK-3β.
Molecular Weight
512.53
Molecular Formula
C28H25FN6O3
Targets
GSK-3α: 1.5 nM; GSK-3β: 0.9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 93 mg/mL (181.45 mM); Water: Insoluble; Warmed ethanol: 2 mg/mL (3.9 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LY2090314 can be used to inhibit GSK-3 in studies focusing on oncology and regenerative medicine.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.